Considering the differential expression of the SMAD4-209 and SMAD4-213 transcripts in non-malignant and malignant cells, their expression level ratio might be a sensitive indicator of the malignant status of the tissue and could serve as a biomarker for CRC detection. This evidence concerns the gene SMAD4 and colorectal carcinoma.